Olivier Micheau
Olivier Micheau is an expert in Biochemistry at INSERM (France). Olivier Micheau has authored 110 publications, the most recent in 2026. SLR score: 430 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Hematology - Urology - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 110
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Efficient generation of isogenic FADD -/-, RIPK1 -/- and Caspase-8 -/- cells using a the ptARgenOM non-viral CRISPR-Cas9 system. PMID 42276705 — cells, genes, caspase 8, clustered regularly interspaced short palindromic repeats, rna, guide, kinetoplastida, caspases | Methods Cell Biol | 2026 | 0 |
| Quantifying loss of cell viability or adhesion using methylene blue. PMID 42061996 — cells, tissue adhesions, cell survival, methylene blue, cell death | Methods Cell Biol | 2026 | 0 |
| to: Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. PMID 40165733 — cells, hematology, quercetin, hodgkin disease, lymphoma, survivin, lymphoma, non-hodgkin, apoptosis, down-regulation, b-lymphocytes | Haematologica | 2025 | 0 |
| Comment on "Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy". PMID 39810374 — cells, neoplasms, cluster analysis, receptors, death domain, therapeutics, nanotechnology, cell death | ACS Nano | 2025 | 1 |
| Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors. PMID 37380559 — apoptosis, ligands, tumor necrosis factor-alpha, cells, therapeutics, urinary bladder neoplasms, urology, classification, cell line, muscles, proteogenomics, non-muscle invasive bladder neoplasms | Eur Urol | 2023 | 16 |
LeadR Networks
Main global connection map